“Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients”., rev. colomb. neumol., vol. 31, no. 2, Dec. 2020, doi: 10.30789/rcneumologia.v31.n2.2019.451.